{
    "2021-03-19": [
        [
            {
                "time": "",
                "original_text": "医药生物行业：业绩弹性逐步释放 关注一季报高增长品种",
                "features": {
                    "keywords": [
                        "医药生物",
                        "业绩弹性",
                        "一季报",
                        "高增长"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "两例引入战投案获放行，定增监管边界或趋明晰",
                "features": {
                    "keywords": [
                        "引入战投",
                        "定增",
                        "监管边界",
                        "趋明晰"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}